Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-21-001582
Filing Date
2021-04-28
Accepted
2021-04-28 17:00:09
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT xenetic_10ka.htm 10-K/A 242055
2 CERTIFICATION xenetic_ex3103.htm EX-31.3 3754
3 CERTIFICATION xenetic_ex3104.htm EX-31.4 3844
  Complete submission text file 0001683168-21-001582.txt   250853
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37937 | Film No.: 21865134
SIC: 2834 Pharmaceutical Preparations